Tag Archives: acute myeloid leukemia (AML)

QIAGEN and Servier Collaborate to Develop Diagnostic Test for Hard-to-Treat Blood Cancer

(IN BRIEF) QIAGEN has entered into a partnership with global pharmaceutical group, Servier, to develop a companion diagnostic test for TIBSOVO, an isocitrate dehydrogenase-1 (IDH1) inhibitor used to treat acute myeloid leukemia (AML). QIAGEN will develop and validate a real-time … Read the full press release